Curaleaf posts record Q3 2026 revenue and narrows loss while pursuing Aurora Cannabis acquisition
Curaleaf Holdings reported third‑quarter 2026 net revenue of about $353 million, up roughly 11% year‑over‑year, with adjusted gross margin of 49% and adjusted EBITDA of $78 million. The quarter posted a net loss of $37 million, or $0.14 per share, better than analysts’ expectations. CEO Boris Jordan said the company is enhancing its offer to acquire Aurora Cannabis and expects full‑year operating cash flow of about $150 million.
Why it matters
The revenue beat and narrower loss may support the stock’s recent price gains, while the pending Aurora bid could reshape Curaleaf’s market position and affect future cash flow. The company also guided Q4 revenue to grow only 1‑2% sequentially, indicating limited near‑term upside.
Key facts
- 1Net revenue for Q3 2026 was $353 million, an 11% year‑over‑year increase. prnewswire.com
- 2Adjusted gross margin for the quarter was 49%. prnewswire.com
- 3Adjusted EBITDA for Q3 2026 was $78 million. prnewswire.com
- 4Net loss from continuing operations was $37 million, or $0.14 per share. finance.yahoo.com
- 5Cash on hand at quarter end was $105 million. prnewswire.com
- 6The company repurchased 105,440 shares for a total of $1 million. prnewswire.com
Summary written by AlphAI AI Desk from 8 of 8 sources. Not investment advice. Figures are as stated by the linked sources.